Rifadin Inh 450 mg/300 mg Tablet
By Rifadin Inh
Rx
7 Tablet in a Strip

Composition
Rifampicin(450mg) + Isoniazid(300mg)

Manufacturer - Sanofi India Ltd
Sanofi House, CTS No.117-B, L&T Business Park, Saki Vihar Road, Powai, Mumbai 400072

Expires on or after
August, 2025

liver
When taking Rifadin Inh 450 mg/300 mg Tablet, it is essential to exercise caution if you have liver disease. Patients with liver issues may require a dose adjustment, so consulting your doctor before starting this medication is crucial. It is advised not to use Rifadin Inh 450 mg/300 mg Tablet in cases of severe liver disease. Your doctor can provide specific guidance tailored to your liver health status.

kidney
Rifadin Inh 450 mg/300 mg Tablet requires caution in patients with kidney disease. Adjusting the dose may be necessary. Please consult your doctor before using Rifadin Inh 450 mg/300 mg Tablet.

alcohol
When using Rifadin Inh 450 mg/300 mg Tablet, avoid alcohol to prevent symptoms like flushing, rapid heart rate, nausea, chest pain, and low blood pressure. This can cause a Disulfiram reaction.

driving
Rifadin Inh 450 mg/300 mg Tablet may cause side effects like fits, mental health problems, and optic neuritis, which could impair your ability to drive. This may affect your driving ability, so caution is advised.

pregnancy
Rifadin Inh 450 mg/300 mg Tablet may not be safe to use during pregnancy. Animal studies suggest potential harm to the developing baby. Your doctor will assess the risks and benefits before prescribing. Please consult your doctor before using.

breastfeeding
Rifadin Inh 450 mg/300 mg Tablet can be used safely during breastfeeding. Studies show that it has minimal transfer to breastmilk and is not harmful to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | - |
Action Class | - |
₹39.54
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025